Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... the head and neck. Six patients received RT only, and five patients received concurrent chemoradiotherapy. All patients showed improvements in their oral mucositis after topical treatment with ...
2009 NOV 16 ... Research findings, 'Stage-for-stage comparison of definitive chemoradiotherapy, surgery alone and neoadjuvant chemotherapy for oesophageal carcinoma,' are discussed ...
2009 NOV 16 ... Kusumoto and colleagues published their study in Oncology Reports (Induction chemoradiotherapy followed by surgery for locally advanced non-small cell lung cancer. Oncology Reports, ...
2009 NOV 9 ... cartilage invasion (BCI) traditionally have been treated with resection followed up with chemoradiotherapy (CRT). Because the organ preservation trials, more patients with BCI, as well as those ...
2009 NOV 16 ... of head and neck cancer. This clinical study focuses on laryngeal function-preserving chemoradiotherapy for locally advanced hypopharyngeal and laryngeal cancer," scientists in Shinkawa, ...
2009 NOV 23 ... outcomes in patients with stage III non-small cell lung cancer receiving concurrent chemoradiotherapy,' are detailed in a study published in Japanese Journal of Clinical Oncology. "To ...
2009 NOV 9 ... The researchers concluded: "Our regimen is an attractive alternative to sequential chemoradiotherapy programs." Boulmay and colleagues published their study in American ...
2009 NOV 23 ... scheduled for curative treatment, of whom 29 patients for surgery and 14 patients for chemoradiotherapy," wrote T.S. Aukema and colleagues. The researchers concluded: "In this ...
2009 NOV 16 ... Technology in Cancer Research & Treatment, "Combined modality treatment (neoadjuvant chemoradiotherapy followed by surgery) for locally advanced rectal cancer requires special attention to ...
2009 NOV 1 ... larynx with perioperative adenovirus-p53 (INGN 201.) gene therapy along with surgery and chemoradiotherapy. A phase 2 study in a multi-institutional setting within the Southwest Oncology Group." ...
2009 NOV 23 ... therapy. Radiotherapy is fundamental to treatment of early-stage disease with a role for chemoradiotherapy among high-risk patients. The clinical course of advanced disease is highly aggressive ...
2009 NOV 9 ... the feasibility and safety of early postoperative chemotherapy followed by concurrent chemoradiotherapy. Eligible patients had resected, stages III to IV HNSCC with positive margins, ...
2009 NOV 23 ... "Mature results are presented from a phase II trial of postoperative concurrent chemoradiotherapy in patients with poor-prognosis cancer of the esophagus and gastroesophageal junction ...
2009 NOV 2 ... neoadjuvant chemotherapy without subsequent surgery, 12 (24.5%) received definitive chemoradiotherapy (dCRT), and 22 (44.9%) received palliative treatment. Survival in patients with EDFE was ...
2009 NOV 9 ... According to recent research from Nakamichi, Japan, "Preoperative chemoradiotherapy is one of the key strategies for the improvement of survival in pancreatic cancer; ...
2009 NOV 23 ... status and quality of life in advanced head and neck cancer patients receiving chemoradiotherapy,' are discussed in a new report. According to a study from New Zealand, ...
2009 NOV 16 ... database of esophageal cancer patients identified 58 patients who underwent neoadjuvant chemoradiotherapy. Operative complications, tolerance of neoadjuvant therapy, and nutritional outcomes ...
2009 NOV 16 ... Bangalore, India described that the addition of nimotuzumab to radiotherapy (RT) and chemoradiotherapy (CRT) had an important effect on overall survival. At 48 months, 41% of the patients in ...
